Longevity research baseline: animal benefit and biological tradeoffs
Transhumanism · NIH research summary · Historical background
Source / event date: National Institute on Aging, 2012 research summary; historical baseline. Added October 21, 2026.
What happened: NIH-supported mouse research examined rapamycin’s effects on mTOR pathways and glucose regulation alongside longevity-related mechanisms.
Why we track it: Establish a baseline for evaluating later claims about enhancement: mechanism, species, benefit and adverse effects all matter.
Assessment: Historical animal research is not a current human treatment recommendation or evidence of human immortality.